Abcellera Biologics Inc (ABCL)

$5.11 +0.09 (1.79%)
Market Cap 1.49B
Revenue (ttm) 28.83M
Net Income (ttm) -162.86M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -564.90%
Debt to Equity Ratio 0.00
Volume 5,179,000
Avg Vol 6,580,036
Day's Range N/A - N/A
Shares Out 298.42M
Stochastic %K 59%
Beta 0.62
Analysts Strong Sell
Price Target $9.14

Company Profile

AbCellera Biologics Inc. engages in discovering and developing antibody-based medicines for indications with unmet medical need in the United States. Its product pipeline includes ABCL635, an antibody-drug candidate, which is in preclinical trial to treat metabolic and endocrine conditions; and ABCL575, a fully human, half-life extended monoclonal antibody, which is in preclinical trial for treating T-cell-mediated autoimmune conditions, such as atopic dermatitis. The company has a research coll...

Industry: Biotechnology
Sector: Healthcare
Phone: 604 559 9005
Address:
150 West 4th Ave, Vancouver, Canada
RocroBio
RocroBio Jul. 25 at 10:40 PM
$ABCL
1 · Reply
TheDrunkTrader69
TheDrunkTrader69 Jul. 25 at 7:55 PM
$ABCL Shes eyeballing that 5.25
0 · Reply
Amires
Amires Jul. 25 at 7:06 PM
$ABCL another happy Friday... I won t be around next week, but good luck with you guys... I will try drop a line here and there... but I am looking forward to start into 6 when I return... With this momentum and stabilization, maybe I will get surprised.... Good Luck to all and keep tight... Buy as much as possible at these levels, from our fellow shorters... whoever has remained, is definitely not knowing what they are doing... Their loss is our gain ;-)
0 · Reply
estatebuyersmia
estatebuyersmia Jul. 25 at 6:43 PM
$ABCL This stock trades like something is coming..
0 · Reply
estatebuyersmia
estatebuyersmia Jul. 25 at 6:42 PM
$ABCL OMG
0 · Reply
Ripvip
Ripvip Jul. 25 at 6:39 PM
$ABCL this is going up in a big way and will make many happy converts to AI Thank you for holding. You all deserve the payday.
0 · Reply
estatebuyersmia
estatebuyersmia Jul. 25 at 6:33 PM
$ABCL ABCELLERA IS BLESSED, CALL ME CRAZY..
1 · Reply
estatebuyersmia
estatebuyersmia Jul. 25 at 6:28 PM
$ABCL Classic beautiful reversal... This stock trades as it should, it has a mind of its own.. Something is coming... I dont know what but it has that feeling it wants to move higher. Ive never been in a stock like this.. We are all going to make money.. You can smell it..
0 · Reply
TheDrunkTrader69
TheDrunkTrader69 Jul. 25 at 6:28 PM
$ABCL ah oh bears that shorted today fell for a classic , we got yo money tactic. Thanks fellas 👌
1 · Reply
AdamURAtoFookingNeptune
AdamURAtoFookingNeptune Jul. 25 at 6:13 PM
$ABCL trying to give me an aneurism
0 · Reply
Latest News on ABCL
AbCellera to Report Second Quarter 2025 Financial Results on August 7, 2025

Jul 7, 2025, 4:05 PM EDT - 18 days ago

AbCellera to Report Second Quarter 2025 Financial Results on August 7, 2025

AbCellera Receives Authorization from Health Canada to Initiate a Phase 1 Clinical Trial of ABCL575

May 30, 2025, 1:00 PM EDT - 2 months ago

AbCellera Receives Authorization from Health Canada to Initiate a Phase 1 Clinical Trial of ABCL575

AbCellera Receives Authorization from Health Canada to Initiate the Phase 1 Clinical Trial of ABCL635 for Vasomotor Symptoms Due to Menopause

May 14, 2025, 5:00 PM EDT - 2 months ago

AbCellera Receives Authorization from Health Canada to Initiate the Phase 1 Clinical Trial of ABCL635 for Vasomotor Symptoms Due to Menopause

AbCellera's Microfluidic Cell Culture Patent Affirmed Valid by the U.S. Court of Appeals for the Federal Circuit

May 12, 2025, 3:30 PM EDT - 2 months ago

AbCellera's Microfluidic Cell Culture Patent Affirmed Valid by the U.S. Court of Appeals for the Federal Circuit

AbCellera Presents Positive Preclinical Data on ABCL575 at the 2025 SID Annual Meeting

May 9, 2025, 7:30 PM EDT - 2 months ago

AbCellera Presents Positive Preclinical Data on ABCL575 at the 2025 SID Annual Meeting

AbCellera Biologics Inc. (ABCL) Q1 2025 Earnings Call Transcript

May 8, 2025, 10:33 PM EDT - 2 months ago

AbCellera Biologics Inc. (ABCL) Q1 2025 Earnings Call Transcript

AbCellera Reports Q1 2025 Business Results

May 8, 2025, 4:05 PM EDT - 2 months ago

AbCellera Reports Q1 2025 Business Results

AbCellera Presents Data Showing Preclinical Efficacy of PSMA x CD3 T-Cell Engagers at AACR 2025

Apr 29, 2025, 3:00 PM EDT - 3 months ago

AbCellera Presents Data Showing Preclinical Efficacy of PSMA x CD3 T-Cell Engagers at AACR 2025

AbCellera to Participate at Upcoming Investor Conferences in May and June

Apr 8, 2025, 4:05 PM EDT - 3 months ago

AbCellera to Participate at Upcoming Investor Conferences in May and June

AbCellera to Report First Quarter 2025 Financial Results on May 8, 2025

Apr 3, 2025, 4:05 PM EDT - 4 months ago

AbCellera to Report First Quarter 2025 Financial Results on May 8, 2025

AbCellera Announces Presentation of In Vivo Data on PSMA x CD3 T-Cell Engagers at AACR 2025

Mar 25, 2025, 4:30 PM EDT - 4 months ago

AbCellera Announces Presentation of In Vivo Data on PSMA x CD3 T-Cell Engagers at AACR 2025

AbCellera Biologics Inc. (ABCL) Q4 2024 Earnings Call Transcript

Feb 27, 2025, 11:26 PM EST - 5 months ago

AbCellera Biologics Inc. (ABCL) Q4 2024 Earnings Call Transcript

AbCellera Reports Full Year 2024 Business Results

Feb 27, 2025, 4:05 PM EST - 5 months ago

AbCellera Reports Full Year 2024 Business Results

AbCellera to Participate at Upcoming Investor Conferences in March

Feb 11, 2025, 4:05 PM EST - 5 months ago

AbCellera to Participate at Upcoming Investor Conferences in March

AbCellera to Report Full Year 2024 Financial Results on February 27, 2025

Jan 21, 2025, 4:05 PM EST - 6 months ago

AbCellera to Report Full Year 2024 Financial Results on February 27, 2025

AbCellera Expands Collaboration with AbbVie to Develop Novel T-Cell Engagers for Oncology

Jan 13, 2025, 9:00 AM EST - 6 months ago

AbCellera Expands Collaboration with AbbVie to Develop Novel T-Cell Engagers for Oncology

AbCellera Biologics: Still A Concept Stock

Dec 23, 2024, 4:39 PM EST - 7 months ago

AbCellera Biologics: Still A Concept Stock

AbCellera to Present at Upcoming Investor Conferences in December and January

Nov 21, 2024, 4:05 PM EST - 8 months ago

AbCellera to Present at Upcoming Investor Conferences in December and January

AbCellera Presents Data on Applications of T-Cell Engager Platform at SITC 2024

Nov 7, 2024, 10:05 AM EST - 9 months ago

AbCellera Presents Data on Applications of T-Cell Engager Platform at SITC 2024

AbCellera Biologics Inc. (ABCL) Q3 2024 Earnings Call Transcript

Nov 4, 2024, 7:22 PM EST - 9 months ago

AbCellera Biologics Inc. (ABCL) Q3 2024 Earnings Call Transcript

AbCellera Reports Q3 2024 Business Results

Nov 4, 2024, 4:05 PM EST - 9 months ago

AbCellera Reports Q3 2024 Business Results

AbCellera to Present at Upcoming Investor Conferences in November 2024

Oct 22, 2024, 4:05 PM EDT - 9 months ago

AbCellera to Present at Upcoming Investor Conferences in November 2024

AbCellera: A Platform To Pipeline Transition

Oct 14, 2024, 12:04 PM EDT - 10 months ago

AbCellera: A Platform To Pipeline Transition

AbCellera Announces Presentation on T-cell Engager Platform at the Society for Immunotherapy of Cancer (SITC) Annual Meeting 2024

Oct 4, 2024, 9:00 AM EDT - 10 months ago

AbCellera Announces Presentation on T-cell Engager Platform at the Society for Immunotherapy of Cancer (SITC) Annual Meeting 2024

AbCellera to Report Third Quarter 2024 Financial Results on November 4, 2024

Sep 26, 2024, 4:05 PM EDT - 10 months ago

AbCellera to Report Third Quarter 2024 Financial Results on November 4, 2024

AbCellera to Present at Upcoming Investor Conferences in September

Aug 29, 2024, 4:05 PM EDT - 11 months ago

AbCellera to Present at Upcoming Investor Conferences in September

AbCellera: A Waiting Game With High Uncertainty

Aug 23, 2024, 4:43 AM EDT - 1 year ago

AbCellera: A Waiting Game With High Uncertainty

This Globant Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday

Aug 20, 2024, 9:45 AM EDT - 1 year ago

This Globant Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday

GLOB AVDX LRN PGRU

AbCellera Reports Q2 2024 Business Results

Aug 6, 2024, 4:05 PM EDT - 1 year ago

AbCellera Reports Q2 2024 Business Results

AbCellera and Lilly Expand Collaboration to Develop Antibody Medicines

Jul 31, 2024, 9:00 AM EDT - 1 year ago

AbCellera and Lilly Expand Collaboration to Develop Antibody Medicines

AbCellera to Report Second Quarter 2024 Financial Results on August 6, 2024

Jun 25, 2024, 4:05 PM EDT - 1 year ago

AbCellera to Report Second Quarter 2024 Financial Results on August 6, 2024

AbCellera to Present at the Goldman Sachs 45th Annual Global Healthcare Conference on June 10, 2024

May 28, 2024, 4:05 PM EDT - 1 year ago

AbCellera to Present at the Goldman Sachs 45th Annual Global Healthcare Conference on June 10, 2024

AbCellera Biologics Inc. (ABCL) Q1 2024 Earnings Call Transcript

May 7, 2024, 11:00 PM EDT - 1 year ago

AbCellera Biologics Inc. (ABCL) Q1 2024 Earnings Call Transcript

AbCellera Reports Q1 2024 Business Results

May 7, 2024, 4:05 PM EDT - 1 year ago

AbCellera Reports Q1 2024 Business Results

AbCellera, Viking Global Investors, and ArrowMark Partners Collaborate to Launch New Biotech Companies

May 1, 2024, 9:00 AM EDT - 1 year ago

AbCellera, Viking Global Investors, and ArrowMark Partners Collaborate to Launch New Biotech Companies

AbCellera Presents Data on T-Cell Engagers Against Four Tumor Targets at AACR 2024

Apr 8, 2024, 12:05 PM EDT - 1 year ago

AbCellera Presents Data on T-Cell Engagers Against Four Tumor Targets at AACR 2024

AbCellera to Report First Quarter 2024 Financial Results on May 7, 2024

Apr 3, 2024, 4:05 PM EDT - 1 year ago

AbCellera to Report First Quarter 2024 Financial Results on May 7, 2024

AbCellera to Present at the Bloom Burton Healthcare Conference on April 16, 2024

Mar 19, 2024, 4:05 PM EDT - 1 year ago

AbCellera to Present at the Bloom Burton Healthcare Conference on April 16, 2024

AbCellera to Collaborate with Biogen to Discover Therapeutic Antibodies for Neurological Conditions

Mar 11, 2024, 9:00 AM EDT - 1 year ago

AbCellera to Collaborate with Biogen to Discover Therapeutic Antibodies for Neurological Conditions

BIIB

AbCellera Announces Four Presentations on T-Cell Engagers at AACR 2024

Mar 5, 2024, 4:30 PM EST - 1 year ago

AbCellera Announces Four Presentations on T-Cell Engagers at AACR 2024

AbCellera Announces Resignation of Board Member

Feb 23, 2024, 4:30 PM EST - 1 year ago

AbCellera Announces Resignation of Board Member

AbCellera to Present at Upcoming Investor Conferences in March

Feb 22, 2024, 8:15 PM EST - 1 year ago

AbCellera to Present at Upcoming Investor Conferences in March

AbCellera Biologics Inc. (ABCL) Q4 2023 Earnings Call Transcript

Feb 20, 2024, 11:45 PM EST - 1 year ago

AbCellera Biologics Inc. (ABCL) Q4 2023 Earnings Call Transcript

AbCellera Reports Full Year 2023 Business Results

Feb 20, 2024, 4:05 PM EST - 1 year ago

AbCellera Reports Full Year 2023 Business Results

AbCellera to Report Full Year 2023 Financial Results on February 20, 2024

Jan 23, 2024, 4:05 PM EST - 1 year ago

AbCellera to Report Full Year 2023 Financial Results on February 20, 2024

AbCellera to Present at the 42nd Annual J.P. Morgan Healthcare Conference on January 10, 2024

Dec 20, 2023, 4:05 PM EST - 1 year ago

AbCellera to Present at the 42nd Annual J.P. Morgan Healthcare Conference on January 10, 2024

Buy AbCellera Biologics's Revolutionizing AI-Powered Drug Development Platform

Dec 7, 2023, 11:39 PM EST - 1 year ago

Buy AbCellera Biologics's Revolutionizing AI-Powered Drug Development Platform

AbCellera to Present at the Piper Sandler 35th Annual Healthcare Conference on November 30, 2023

Nov 16, 2023, 4:05 PM EST - 1 year ago

AbCellera to Present at the Piper Sandler 35th Annual Healthcare Conference on November 30, 2023

AbCellera Presents New Data on Two T-Cell Engager Programs at SITC 2023

Nov 3, 2023, 12:05 PM EDT - 1 year ago

AbCellera Presents New Data on Two T-Cell Engager Programs at SITC 2023

AbCellera Biologics Inc. (ABCL) Q3 2023 Earnings Call Transcript

Nov 2, 2023, 9:18 PM EDT - 1 year ago

AbCellera Biologics Inc. (ABCL) Q3 2023 Earnings Call Transcript

RocroBio
RocroBio Jul. 25 at 10:40 PM
$ABCL
1 · Reply
TheDrunkTrader69
TheDrunkTrader69 Jul. 25 at 7:55 PM
$ABCL Shes eyeballing that 5.25
0 · Reply
Amires
Amires Jul. 25 at 7:06 PM
$ABCL another happy Friday... I won t be around next week, but good luck with you guys... I will try drop a line here and there... but I am looking forward to start into 6 when I return... With this momentum and stabilization, maybe I will get surprised.... Good Luck to all and keep tight... Buy as much as possible at these levels, from our fellow shorters... whoever has remained, is definitely not knowing what they are doing... Their loss is our gain ;-)
0 · Reply
estatebuyersmia
estatebuyersmia Jul. 25 at 6:43 PM
$ABCL This stock trades like something is coming..
0 · Reply
estatebuyersmia
estatebuyersmia Jul. 25 at 6:42 PM
$ABCL OMG
0 · Reply
Ripvip
Ripvip Jul. 25 at 6:39 PM
$ABCL this is going up in a big way and will make many happy converts to AI Thank you for holding. You all deserve the payday.
0 · Reply
estatebuyersmia
estatebuyersmia Jul. 25 at 6:33 PM
$ABCL ABCELLERA IS BLESSED, CALL ME CRAZY..
1 · Reply
estatebuyersmia
estatebuyersmia Jul. 25 at 6:28 PM
$ABCL Classic beautiful reversal... This stock trades as it should, it has a mind of its own.. Something is coming... I dont know what but it has that feeling it wants to move higher. Ive never been in a stock like this.. We are all going to make money.. You can smell it..
0 · Reply
TheDrunkTrader69
TheDrunkTrader69 Jul. 25 at 6:28 PM
$ABCL ah oh bears that shorted today fell for a classic , we got yo money tactic. Thanks fellas 👌
1 · Reply
AdamURAtoFookingNeptune
AdamURAtoFookingNeptune Jul. 25 at 6:13 PM
$ABCL trying to give me an aneurism
0 · Reply
estatebuyersmia
estatebuyersmia Jul. 25 at 6:10 PM
$ABCL WOW...
0 · Reply
AGC_Trader
AGC_Trader Jul. 25 at 5:26 PM
$ABCL This stock had one mission today: fill the $4.70-4.80 gap before it could continue the uptrend
0 · Reply
Odoji
Odoji Jul. 25 at 5:22 PM
$ABCL
0 · Reply
TheDrunkTrader69
TheDrunkTrader69 Jul. 25 at 5:21 PM
$ABCL hehehehe. Up
0 · Reply
Knanzlelc
Knanzlelc Jul. 25 at 4:56 PM
$ABCL worth the buy? 🐂 vs. 🧸
2 · Reply
estatebuyersmia
estatebuyersmia Jul. 25 at 4:55 PM
$ABCL hopefully closes positive
0 · Reply
Thenextgme
Thenextgme Jul. 25 at 4:01 PM
$ABCL shorties trying to run by lowering price before hours and getting this guy to publish an incomplete picture of the company… don’t let them out folks. Hold on to your shares.
1 · Reply
TheDrunkTrader69
TheDrunkTrader69 Jul. 25 at 3:55 PM
$ABCL 5.25 end of day.
0 · Reply
GiavannaWilcox
GiavannaWilcox Jul. 25 at 3:27 PM
$ABCL $JDZG $BYDDF WKSP 🚀 FSMAX buys 16K shares! Big move from Fidelity. Q2 rev +83%, patent + DOE grant 💰 Microcap heating up 🔥 5m
1 · Reply
TheDrunkTrader69
TheDrunkTrader69 Jul. 25 at 3:02 PM
$ABCL OMG its a red day lol if you bought this morning when i did your still up 3% on a bad day
1 · Reply
50bps
50bps Jul. 25 at 1:59 PM
$ABCL reloaded. ty
0 · Reply
Hofgrouuunder
Hofgrouuunder Jul. 25 at 1:59 PM
$ABCL Ready for liftoff
0 · Reply